The impact of increased utilization of HIV drugs on longevity and medical expenditure: an assessment based on aggregate US time-series data.
The objective of this Special Report is to estimate the medical cost per life-year gained from increased utilization of HIV drugs by estimating the impact of increased drug utilization on the life expectancy and drug and hospital expenditure of HIV/AIDS patients, using aggregate (US national-level) data for the period 1982-2001.
Professor, Graduate School of Business, Columbia University and Research Associate, National Bureau of Economic Research Mailing address: 614 Uris Hall, 3022 Broadway, New York, NY 10027, USA. frank.lichtenberg@columbia.edu.
Frank R
FR
Lichtenberg